J Korean Med Sci.  2008 Aug;23(4):644-650. 10.3346/jkms.2008.23.4.644.

Insulin Resistance is Associated with Gallstones Even in Non-obese, Non-diabetic Korean Men

• Chang Y
• Sung E
• Ryu S
• Park YW
• Jang YM
• Park M

• KMID: 1785823
• DOI: http://doi.org/10.3346/jkms.2008.23.4.644

Abstract

It remains unclear as to whether insulin resistance alone or in the presence of wellknown risk factors, such as diabetes or obesity, is associated with gallstones in men. The aim of this study was to determine whether insulin resistance is associated independently with gallstone disease in non-diabetic men, regardless of obesity. Study subjects were 19,503 Korean men, aged 30-69 yr, with fasting blood glucose level <126 mg/dL and without a documented history of diabetes. Gallbladder status was assessed via abdominal ultrasonography after overnight fast. Body mass index and waist circumference were measured. Insulin resistance was estimated by the Homeostasis Model Assessment of insulin resistance (HOMA-IR). The prevalence of obesity, abdominal obesity, and metabolic syndrome in the subjects with gallstones were higher than in those without. The prevalence of elevated HOMA (>75 percentile) in subjects with gallstones was significantly higher than in those without, and this association remained even after the obesity stratification was applied. In multiple logistic regression analyses, only age and HOMA proved to be independent predictors of gallstones. Insulin resistance was positively associated with gallstones in non-diabetic Korean men, and this occurred regardless of obesity. Gallstones appear to be a marker for insulin resistance, even in non-diabetic, nonobese men.

Keyword

Gallstones; Insulin Resistance; Body Mass Index; Obesity

MeSH Terms

Adult
Aged
Aged, 80 and over
Body Mass Index
Gallstones/*etiology
Humans
*Insulin Resistance
Logistic Models
Male
Middle Aged
Obesity/complications
Risk Factors

Reference

1. Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology. 1999. 117:632–639.

2. Diehl AK. Cholelithiasis and the Insulin Resistance Syndrome. Hepatology. 2000. 31:528–530.

3. Ruhl CE, Everhart JE. Association of diabetes, serum insulin, and C-peptide with gallbladder disease. Hepatology. 2000. 31:299–303.

4. De Santis A, Attili AF, Ginanni Corradini S, Scafato E, Cantagalli A, De Luca C, Pinto G, Lisi D, Capocaccia L. Gallstones and diabetes: a case-control study in a free-living population sample. Hepatology. 1997. 25:787–790.

5. Maurer KR, Everhart JE, Knowler WC, Shawker TH, Roth HP. Risk factors for gallstone disease in the Hispanic populations of the United States. Am J Epidemiol. 1990. 131:836–844.

6. Kono S, Shinchi K, Todoroki I, Honjo S, Sakurai Y, Wakabayashi K, Imanishi K, Nishikawa H, Ogawa S, Katsurada M. Gallstone disease among Japanese men in relation to obesity, glucose intolerance, exercise, alcohol use, and smoking. Scand J Gastroenterol. 1995. 30:372–376.

7. Barbara L, Sama C, Morselli-Labate AM, Taroni F, Rusticali AG, Festi D, Sapio C, Roda E, Banterle C, Puci A, Formentini F, Colasanti S, Nardin F. A population study on the prevalence of gallstone disease: the Sirmione study. Hepatology. 1987. 7:913–917.

8. Jorgensen T. Gallstones in a Danish population. Relation to weight, physical activity smoking, coffee consumption, and diabetes mellitus. Gut. 1989. 30:528–534.

9. Heaton KW, Braddon FE, Mountford RA, Hughes AO, Emmett PM. Symptomatic and silent gall stones in the community. Gut. 1991. 32:316–320.

10. Haffner SM, Diehl AK, Mitchell BD, Stern MP, Hazuda HP. Increased prevalence of clinical gallbladder disease in subjects with non-insulin-dependent diabetes mellitus. Am J Epidemiol. 1990. 132:327–335.

11. Gonzalez Villalpando C, Rivera Martinez D, Arredondo Perez B, Martinez Diaz S, Gonzalez Villalpando ME, Haffner SM, Stern MP. High prevalence of cholelithiasis in a low income Mexican population: an ultrasonographic survey. Arch Med Res. 1997. 28:543–547.

12. Misciagna G, Guerra V, Di Leo A, Correale M, Trevisan M. Insulin and gallstones: a population case control study in southern Italy. Gut. 2000. 47:144–147.

13. Shaffer EA. Gallstone disease: epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol. 2006. 20:981–996.

14. Sahi T, Puffenbarger RS Jr, Hseih CC, Lee IM. Body mass index, cigarette smoking and other characteristics as predictors of self-reported, physician-diagnosed gallbladder disease in male college alumni. Am J Epidemiol. 1998. 147:644–651.

15. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Prospective study of abdominal adiposity and gallstone disease in US men. Am J Clin Nutr. 2004. 80:38–44.

16. Grundy SM. Cholesterol gallstones: a fellow traveler with metabolic syndrome? Am J Clin Nutr. 2004. 80:1–2.

17. Tan CE, Chew SK, Ma S, Tai ES, Wai D. Can we apply the National Cholesterol Education Program Adult Treatment Panel Definition of the Metabolic Syndrome to Asians? Diabetes Care. 2004. 27:1182–1186.

18. Chang Y, Ryu S, Sung E, Jang Y. Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem. 2007. 53:686–692.

19. Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001. 285:2486–2497.

20. WHO Western Pacific Region, IASO and IOTF. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. 2000. Sydney, Australia: Health Communications Australia Pty Limit.

21. The IDF consensus worldwide definition of the metabolic syndrome. 2005. 04. 14. accessed June 10, 2005. International Diabetes Federation;Available at: http://www.idf.org/webdata/docs/Metac_syndrome_def.pdf.

22. Scragg RK, Calvert GD, Oliver JR. Plasma lipids and insulin in gallstone disease: a case-control study. Br Med J. 1984. 289:521–525.

23. Laakso M, Suhonen M, Julkunen R, Pyorala K. Plasma insulin, serum lipids and lipoproteins in gallstone disease in non-insulin-dependent diabetic subjects: a case control study. Gut. 1990. 31:344–347.

24. Mendez-Sanchez N, Chavez-Tapia NC, Motola-Kuba D, Sanchez-Lara K, Ponciano-Rodriguez G, Baptista H, Ramos MH, Uribe M. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol. 2005. 11:1653–1657.

25. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res. 1998. 6:Suppl 2. 51S–209S.

26. Dowling RH. Review: pathogenesis of gallstones. Aliment Pharmacol Ther. 2000. 14:Suppl 2. 39–47.

27. Bennion LJ, Grudy SM. Effects of diabetes mellitus on cholesterol metabolism in men. N Engl J Med. 1977. 296:1365–1371.

28. Nepokroeff CM, Lakshmanan MR, Ness GC, Dugan RE, Porter JW. Regulation of the diurnal rhythm of rat liver beta-hydroxy-beta-methylglutaryl coenzyme A reductase activity by insulin, glucagons, cyclic AMP and hydrocortisone. Arch Biochem Biophys. 1974. 160:387–396.

29. Kim MH, Lim BC, Myung SJ, Lee SK, Ohrr HC, Kim YT, Roe IH, Kim JH, Chung JB, Kim CD, Shim CS, Yun YB, Min YI, Yang US, Kang JK. Epidemiological Study on Korean Gallstone Disease. A Nationwide Cooperative Study. Dig Dis Sci. 1999. 44:1674–1683.

30. Park YH, Park SJ, Jang JY, Ahn YJ, Park YC, Yoon YB, Kim SW. Changing patterns of gallstone disease in KOREA. World J Surg. 2004. 28:206–210.